BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  City of Hope Opens Phase 1 Clinical Trial Aiming to One Day Transform Rectal Cancer Into a Disease Treatable With Radiation Therapy to Avoid Potential Long-Term Side Effects of Surgery

  March 26, 2025

   · 

  3 min read
• Press Releases

  Restore Robotics Receives FDA 510(k) Clearance for Remanufacturing Da Vinci Xi 8mm Monopolar Curved Scissors

  March 26, 2025

   · 

  2 min read
• Press Releases

  Ontario Brain Institute partners with EpiSign to advance diagnosis of rare genetic disorders

  March 26, 2025

   · 

  3 min read
• Press Releases

  Hubble Therapeutics closes Series A Financing to develop gene therapy cure for LCA16

  March 26, 2025

   · 

  4 min read
• Press Releases

  Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

  March 26, 2025

   · 

  2 min read
• Press Releases

  Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan

  March 26, 2025

   · 

  6 min read
• 

  GLP-1

  BioSpace Presents the World Atlas of GLP-1s

  Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the territory covered and what’s to come.

  March 26, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Paving the Way for Early Esophageal Cancer Detection:

  March 26, 2025

   · 

  2 min read
• Press Releases

  Vast Granted Qualified Infectious Disease Product Designation from the FDA

  March 26, 2025

   · 

  3 min read
• 

  Podcast

  Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More

  President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC director nominee; Novo Nordisk joins the triple-G race; Alnylam wins approval for Amvuttra in ATTR-CM; and Cassava Sciences ends development of simufilam in Alzheimer’s.

  March 26, 2025

   · 

  1 min read

   · 

  Heather McKenzie